Altre lingue Alpha Cognition Inc.

Azioni

ACOG

CA02074J2048

Mercato chiuso - Canadian Securities Exchange Altri mercati azionari 21:17:34 27/06/2024			Variaz. 5gg	Var. 1 gen.
0,66 ^CAD	0,00%		-15,38%	0,00%

15/05	Alpha Cognition Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
04/04	La perdita globale del quarto trimestre di Alpha Cognition si allarga un po' rispetto all'anno precedente	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04/04
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01/03
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22/02
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22/02
Alpha Cognition Provides Business Update	12/02
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	19/01
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19/01
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	22/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08/12
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	07/12
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	07/12
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05/12
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05/12
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	08/11
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	16/10/23
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	02/10/23
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	27/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Alpha Cognition Inc.

Azioni

ACOG

CA02074J2048

Altre lingue

Filtri